Compare Fimperkasa Utama Tbk. (FIMP) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fimperkasa Utama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Fimperkasa Utama Tbk. trades at Rp69 (market cap 27.6B), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 447.8× Fimperkasa Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| FIMP | TSPC | |
|---|---|---|
Market Cap | 27.6B | 12.36T |
Volume | — | 1.41M |
Lot | — | 14.08K |
Turnover | — | 3.83B |
Average Price | — | 2,722.04 |
Value | — | 3.83B |
Indicative Equilibrium Price | — | 2,730 |
Indicative Equilibrium Volume | — | 2.51K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fimperkasa Utama Tbk.
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Read more on FIMP →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
